EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Aquestive Therapeutics, Inc.
AQST

AQST Aquestive Therapeutics, Inc.

Aquestive Therapeutics, Inc. · NASDAQ
Market Closed
4.78
▼ ⁦-4.21%⁩ (-0.21)
Market Cap$599.7M
Beta1.43
52w Low52w High
2.937.55
Last Week
⁦-11.15%⁩
Last Month
⁦+21.32%⁩
Last 3 Months
⁦+18.91%⁩
Last Year
⁦+24.16%⁩
EL7 Factor Analysis
How we score this
Overall11
Poor — bottom quartile of the marketHigh FlyerF 2/9Better than 11% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
13
—17.8xBottom tier
▸
Growth
44
22.6%▲7.1%Around median
▸
Quality
93
—4.5%Top tier
▸
Safety
12
—2.6xBottom tier
▸
Capital Return
29
—2.12%Bottom tier
▸
Momentum
57
0.5%▼2.9%Around median
▸
Sentiment
36
4▲3Bottom tier

Frequently Asked Questions

What is Aquestive Therapeutics, Inc. stock?▼

Aquestive Therapeutics, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Aquestive Therapeutics, Inc.?▼

You can buy Aquestive Therapeutics, Inc. shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Aquestive Therapeutics, Inc.?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Aquestive Therapeutics, Inc. pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Aquestive Therapeutics, Inc.?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Fair Value
Low confidenceCurrent price$4.78
Analyst target · 3 analysts
$11
—
Range ⁦$11–$11⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 3 analysts setting price target
$11.00
⁦+130.1%⁩
Current Price $4.78·Median $11.00
Low
$11.00
High
$11.00
Street summary

Raising the Target Price with Valuations Unchanged

Bullish tilt

The consensus target price rose from 9.75 to 11 over the last 7 and 30 days, an increase of 1.25 or 12.82%, while the number of analysts remained at 3. There is no dispersion among the estimates, as the high, low, median, and consensus levels all match at 11, reflecting a high degree of consistency across the limited coverage available. The target price is also higher than the current price of 4.78.

As of 2026-09-11
Revisions momentum · 30d
⁦+12.8%⁩
Average rating
★ 4.22
Buy
Analyst coverage
9
Buy conviction
100%
High
Rating activity · 30d
0↑ · 0↓
Target dispersion
0%
Analyst ratings over time9 analysts rating
2
7
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.22 → 4.22
Recent analyst moves
  • = Reiterate2026-09-10
    Cantor Fitzgerald
    Overweight
  • = Reiterate2026-02-03
    Lake Street
    —· $6.00
  • = Reiterate2026-02-02
    New Street
    —· $12.00
Premium content
Financial Analysis
|